Andrew Tilston-Lunel

Dr. Andrew Tilston-Lunel

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2012 in Oncogene
Verified
Journal Article
Closed access
SMS Moleirinho
S Moleirinho
NCN Chang
N Chang
ASAndrew H Sims
Andrew H Sims
ATAndrew Tilston-Lunel
Andrew Tilston-Lunel
LAL Angus
L Angus
PRPaul Reynolds
Paul Reynolds

10 May 2013 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
SMSusana Moleirinho
Susana Moleirinho
ATAndrew Tilston-Lunel
Andrew Tilston-Lunel
LALiselotte Angus
Liselotte Angus
FGFrank J. Gunn-Moore
Frank J. Gunn-Moore
PRPaul Reynolds
Paul Reynolds
Our understanding of the FERM (4.1/ezrin/radixin/moesin) protein family has been rapidly expanding in the last few years, with the result that many new physiological functions have been ascribed to these biochemically unique proteins. In the present review, we will discuss a number of new FRMD (FERM domain)-containing proteins that were initially discovered from genome sequencing but are now being established through biochemical and genetic studies to be involved both in normal cellular processes, but are also associated with a variety of human diseases.

27 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
ARAhmed A. Raslan
Ahmed A. Raslan
TPTho X. Pham
Tho X. Pham
JLJisu Lee
Jisu Lee
KKKonstantinos Kontodimas
Konstantinos Kontodimas
ATAndrew Tilston-Lunel
Andrew Tilston-Lunel
GLGiovanni Ligresti
Giovanni Ligresti
Progressive lung fibrosis is associated with poorly understood aging-related endothelial cell dysfunction. To gain insight into endothelial cell alterations in lung fibrosis we performed single cell RNA-sequencing of bleomycin-injured lungs from young and aged mice. Analysis reveals activated cell states enriched for hypoxia, glycolysis and YAP/TAZ activity in ACKR1+ venous and TrkB+ capillary endothelial cells. Endothelial cell activation is prevalent in lungs of aged mice and can also be detected in human fibrotic lungs. Longitudinal single cell RNA-sequencing combined with lineage tracing demonstrate that endothelial activation resolves in young mouse lungs but persists in aged ones, indicating a failure of the aged vasculature to return to quiescence. Genes associated with activated lung endothelial cells states in vivo can be induced in vitro by activating YAP/TAZ. YAP/TAZ also cooperate with BDNF, a TrkB ligand that is reduced in fibrotic lungs, to promote capillary morphogenesis. These findings offer insights into aging-related lung endothelial cell dysfunction that may contribute to defective lung injury repair and persistent fibrosis.

1 July 2021 in Cell Reports
Verified
Journal Article
Open access
JHJulia Hicks-Berthet
Julia Hicks-Berthet
BNBoting Ning
Boting Ning
AFAnthony Federico
Anthony Federico
ATAndrew Tilston-Lunel
Andrew Tilston-Lunel
AMAdeline Matschulat
Adeline Matschulat
XVXaralabos Varelas
Xaralabos Varelas
Proper lung function relies on the precise balance of specialized epithelial cells that coordinate to maintain homeostasis. Herein, we describe essential roles for the transcriptional regulators YAP/TAZ in maintaining lung epithelial homeostasis, reporting that conditional deletion of Yap and Wwtr1/Taz in the lung epithelium of adult mice results in severe defects, including alveolar disorganization and the development of airway mucin hypersecretion. Through in vivo lineage tracing and in vitro molecular experiments, we reveal that reduced YAP/TAZ activity promotes intrinsic goblet transdifferentiation of secretory airway epithelial cells. Global gene expression and chromatin immunoprecipitation sequencing (ChIP-seq) analyses suggest that YAP/TAZ act cooperatively with TEA domain (TEAD) transcription factors and the NuRD complex to suppress the goblet cell fate program, directly repressing the SPDEF gene. Collectively, our study identifies YAP/TAZ as critical factors in lung epithelial homeostasis and offers molecular insight into the mechanisms promoting goblet cell differentiation, which is a hallmark of many lung diseases.

8 April 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SMSusana Moleirinho
Susana Moleirinho
CPCalum Patrick
Calum Patrick
ATAndrew Tilston-Lunel
Andrew Tilston-Lunel
JHJennifer R Higginson
Jennifer R Higginson
LALiselotte Angus
Liselotte Angus
FGFrank J. Gunn-Moore
Frank J. Gunn-Moore
Willin/FRMD6 was first identified in the rat sciatic nerve, which is composed of neurons, Schwann cells, and fibroblasts. Willin is an upstream component of the Hippo signaling pathway, which results in the inactivation of the transcriptional co-activator YAP through Ser127 phosphorylation. This in turn suppresses the expression of genes involved in cell growth, proliferation and cancer development ensuring the control of organ size, cell contact inhibition and apoptosis. Here we show that in the mammalian sciatic nerve, Willin is predominantly expressed in fibroblasts and that Willin expression activates the Hippo signaling cascade and induces YAP translocation from the nucleus to the cytoplasm. In addition within these cells, although it inhibits cellular proliferation, Willin expression induces a quicker directional migration towards scratch closure and an increased expression of factors linked to nerve regeneration. These results show that Willin modulates sciatic nerve fibroblast activity indicating that Willin may have a potential role in the regeneration of the peripheral nervous system.

29 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
MVMarc A. Vittoria
Marc A. Vittoria
NKNathan Kingston
Nathan Kingston
KKKristyna Kotynkova
Kristyna Kotynkova
EXEric Xia
Eric Xia
RHRui Hong
Rui Hong
NGNeil J. Ganem
Neil J. Ganem
Melanoma is commonly driven by activating mutations in the MAP kinase BRAF; however, oncogenic BRAF alone is insufficient to promote melanomagenesis. Instead, its expression induces a transient proliferative burst that ultimately ceases with the development of benign nevi comprised of growth-arrested melanocytes. The tumor suppressive mechanisms that restrain nevus melanocyte proliferation remain poorly understood. Here we utilize cell and murine models to demonstrate that oncogenic BRAF leads to activation of the Hippo tumor suppressor pathway, both in melanocytes in vitro and nevus melanocytes in vivo. Mechanistically, we show that oncogenic BRAF promotes both ERK-dependent alterations in the actin cytoskeleton and whole-genome doubling events, which independently reduce RhoA activity to promote Hippo activation. We also demonstrate that functional impairment of the Hippo pathway enables oncogenic BRAF-expressing melanocytes to bypass nevus formation and rapidly form melanomas. Our data reveal that the Hippo pathway enforces the stable arrest of nevus melanocytes and represents a critical barrier to melanoma development.